Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Impact of Concentration and Affinity of HLA-DQ Antibodies in Lung Transplantation - AFFIHLA-P

NCT03474536 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT03474536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03474536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Impact of Concentration and Affinity of HLA-DQ Antibodies in Lung Transplantation - AFFIHLA-P
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Completed
Start date
March 14, 2018
Completion date
April 8, 2025
Enrollment
88 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

antibody mediated rejection, chronic lung allograft dysfunction, lung transplantation